Vita 34 AG (ETR:V3V) | WebDisclosure

Basculer en Français

10815	Companies
234327	Keywords
163111	Articles
125300	Press releases

Home
Companies
Vita 34 AG

PRESS RELEASE

published on 11/21/2025 at 07:30, 8 months 19 days ago

FamiCord AG accelerates profitable growth in the third quarter of 2025 and further strengthens quality and visibility of revenues
FamiCord AG accelerates profitable growth in Q3 2025, with Group revenues up 2.5% to EUR 22.8 million. EBITDA reaches EUR 8.7 million. Company focuses on subscription model for revenue stability

Profitable Growth Revenue Stability Subscription Model Q3 2025 FamiCord AG
BRIEF

published on 09/16/2025 at 18:58, 10 months 23 days ago

PBKM, filiale de FamiCord AG, va acquérir la banque de cellules souches nOvum

Acquisition PBKM FamiCord AG Banque De Cellules Souches NOvum
BRIEF

published on 09/16/2025 at 18:58, 10 months 23 days ago

FamiCord AG's Subsidiary PBKM to Acquire nOvum Stem Cell Bank

Acquisition PBKM FamiCord AG NOvum Stem Cell Bank
PRESS RELEASE

published on 09/16/2025 at 18:53, 10 months 23 days ago

EQS-Adhoc: FamiCord AG: Polski Bank Komórek Macierzystych sp. z o. o. is to acquire 100 % in stem cell bank “nOvum” spółka z ograniczoną odpowiedzialnością, Warsaw, Poland
FamiCord AG's subsidiary PBKM to acquire 100% of stem cell bank nOvum in Poland, expanding cord blood services. Purchase price in medium single digit million Euros, financed through credit facilities

Acquisition PBKM FamiCord AG NOvum Cord Blood Services
BRIEF

published on 08/27/2025 at 07:05, 11 months 14 days ago

FamiCord AG annonce une forte croissance de son chiffre d'affaires et de ses bénéfices au premier semestre 2025

Croissance Des Revenus Augmentation De L'EBITDA FamiCord AG Orientation Principale De L'activité Thérapies Par Cellules Souches
BRIEF

published on 08/27/2025 at 07:05, 11 months 14 days ago

FamiCord AG Reports Strong Growth in Revenue and Earnings for H1 2025

Revenue Growth EBITDA Increase Core Business Focus FamiCord AG Stem Cell Therapies
PRESS RELEASE

published on 08/27/2025 at 07:00, 11 months 14 days ago

FamiCord AG significantly increases revenue and earnings in the first half of 2025 and shifts focus even more strongly to core business in the future
FamiCord AG reports 14.6% revenue growth and EUR 5.0 million rise in EBITDA for H1 2025. Focus shifts to core business. Outlook affirmed amid market challenges

Revenue Growth Earnings Financial Outlook Core Business FamiCord AG
BRIEF

published on 05/28/2025 at 16:24, 1 year 2 months ago

FamiCord AG étend sa participation dans les banques de cellules souches

Expansion Européenne FamiCord AG Acquisition De Cellules Souches Thérapies Cellulaires Partenariat Primecell
BRIEF

published on 05/28/2025 at 16:24, 1 year 2 months ago

FamiCord AG Expands Stake in Stem Cell Banks

European Expansion FamiCord AG Stem Cell Acquisition Cell-based Therapies Primecell Partnership
PRESS RELEASE

published on 05/28/2025 at 16:19, 1 year 2 months ago

EQS-Adhoc: FamiCord AG acquires majority stake in Národní Centrum Pupečníkové Krve and Rodinná banka perinatálnych a mezenchymálnych buniek
FamiCord AG acquires majority stake in Národní Centrum Pupečníkové Krve and Rodinná banka perinatálnych a mezenchymálnych buniek from Primecell Advanced Therapy, expanding its stem cell bank services in Europe

Acquisition Europe Majority Stake FamiCord AG Stem Cell Banks

Accesswire

Published on 08/10/2026 at 08:00, 1 hour 42 minutes ago

Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 1 hour 42 minutes ago

Results of AGM and Management Update Presentation
Published on 08/08/2026 at 00:00, 2 days 9 hours ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 2 days 10 hours ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 10 hours ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing

View all ACCESSWIRE

EQS Group

Published on 08/10/2026 at 09:00, 41 minutes ago

Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 41 minutes ago

Original-Research: Bittium Oyj (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 42 minutes ago

Official List Notice
Published on 08/10/2026 at 09:00, 42 minutes ago

Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
Published on 08/10/2026 at 08:30, 1 hour 12 minutes ago

Suspension - Ashington Innovation PLC

Les Echos

Published on 08/10/2026 at 09:22, 19 minutes ago

Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 19 minutes ago

Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 2 hours 42 minutes ago

BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 2 hours 42 minutes ago

Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
Published on 08/07/2026 at 18:54, 2 days 14 hours ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026

View all LES ECHOS COMFI WIRE